How to Buy Retatrutide: Vendor Verification, Pricing, and Sourcing Guide

You cannot buy retatrutide from a pharmacy in any country. The compound holds no marketing approval, and its registrational program, TRIUMPH, consists of four phase 3 multicenter randomized double-blind studies of weekly subcutaneous retatrutide against placebo in over 5800 participants (PMID 41090431). Those have to read out before a prescription route can exist. What is available is research material sold by the vial to qualified organizations at $100 per 10 mg and $195 per 20 mg, which works out to $9.75/mg, prices as of September 2026 from the HEEZ catalog. Verification is analytical rather than regulatory: the certificate of analysis for your specific lot is the entire evidence base.

Where can you buy retatrutide if it is not in pharmacies?

Research-material supply is the only channel. No formulary carries the compound, no pharmacy can fill it, and no insurer has adjudicated it, because none of those systems act on a molecule without a labeled indication. A listing that implies otherwise is describing something that does not exist. What remains is the catalog: the 10 mg and 20 mg vials are the two sizes a US buyer can order online and have shipped domestically, with no import step and no customs exposure.

That absence changes what a buyer is actually evaluating. With an approved drug, the manufacturer’s identity and the label carry the quality claim. With retatrutide, nothing upstream does it for you, so the listing’s analytical documentation is the only thing standing between a labeled milligram figure and the solid in the vial. The distinction between an approved peptide drug and an investigational one, and why published approval lists disagree with each other, is worked through in why approved peptide lists differ.

Two terms on a compliant listing are load-bearing rather than decorative. One defines the permitted application, the other defines who may receive it: material sold on these terms is research use only, and supply is restricted to qualified organizations. HEEZ Research states both, along with the condition that all sales are final, which matters more than it looks like it does once you get to the verification steps below.

Those two terms also decide what a buyer can do with the material after it arrives. Research use only excludes human and veterinary administration, which means the vial is bought to be weighed, reconstituted, assayed or dosed into a model system, and the qualified-organization restriction puts the burden of that framing on the purchaser rather than the seller. Practically, that shapes the paperwork: a research group ordering the compound is expected to hold the material under its own institutional handling rules, log the lot number against the work it supports, and retain the certificate of analysis alongside the experimental record. None of this is enforced at checkout. It is the reason the certificate matters as a record and not only as a screening tool — the document is what ties a result back to a specific batch of solid months after the vial is empty.

What does retatrutide cost by vial size?

Two sizes exist, and the per-mg rate is a function of size alone. The figures come from HEEZ Research’s own catalog, where you can buy retatrutide in either size.

Table 1: HEEZ Research retatrutide sizes with cost per mg derived from them. Price per mg = price ÷ size in mg, so $100 ÷ 10 mg = $10.00/mg and $195 ÷ 20 mg = $9.75/mg. Prices as of September 2026 from the HEEZ catalog.

The 25-cent per-mg gap is smaller than the rounding penalty on a single vial, so sizing an order to a protocol beats chasing the rate. The phase 2 obesity trial dosed once-weekly subcutaneous retatrutide for 48 weeks in 338 adults, with percent change in body weight at 24 weeks as the primary endpoint; the pooled 8 mg arms read −17.3% at 24 weeks and −22.8% at 48 weeks, against −1.6% and −2.1% on placebo (PMID 37366315). Those are phase 2 results and are not comparable to any TRIUMPH readout, since the two programs differ in design, population and endpoints.

Take that protocol’s 8 mg weekly quantity across its full 48 weeks as a material requirement: 48 × 8 = 384 mg. At the 20 mg tier, 384 ÷ 20 = 19.2, rounded up to 20 vials, so 20 × $195 = $3,900. At the 10 mg tier, 384 ÷ 10 = 38.4, rounded up to 39 vials, so 39 × $100 = $3,900. The two tiers tie to the dollar at that quantity, and the smaller vial wins on waste: 39 × 10 = 390 mg bought against 384 needed strands 6 mg, while 20 × 20 = 400 mg strands 16 mg. Shorter blocks and other weekly quantities break the tie in both directions, and those are tabulated in the per-block cost breakdown.

Flat 8 mg for 48 weeks is the worst case for a budget, because the phase 2 protocol did not start there. Weekly doses in that trial were escalated toward the assigned maintenance level over the opening months rather than given at full size from week one (PMID 37366315), so a material estimate built on the maintenance dose alone overstates the early weeks. Model a conservative ramp — 2 mg weekly for weeks 1 through 4, 4 mg for weeks 5 through 12, then 8 mg for the remaining 36 weeks — and the total becomes (4 × 2) + (8 × 4) + (36 × 8) = 8 + 32 + 288 = 328 mg, which is 56 mg less than the flat figure. At the 20 mg tier that is 328 ÷ 20 = 16.4, rounded up to 17 vials for $3,315; at the 10 mg tier it is 33 vials for $3,300. The larger vial now loses by $15 and strands 12 mg against the smaller vial’s 2 mg, which is the general pattern: the 20 mg tier wins on rate and loses on rounding, and which effect dominates depends entirely on the quantity you land on.

What does a retatrutide COA need to show before you order?

Seven fields, each of which fails a specific way when it is missing. Work down them in order; the first two are disqualifying on their own.

Table 2: certificate-of-analysis fields to verify on a retatrutide lot. Checks 1, 3, 4 and 5 correspond to the documentation HEEZ Research states it supplies: a batch-specific third-party COA on every lot covering HPLC purity and MS identity, with purity stated as ≥99% as measured.

Check 5 carries more weight for this compound than for a short peptide. Retatrutide is a synthetic molecule that activates the GIP, GLP-1 and glucagon receptors together (PMID 41090431), and a synthesis long enough to assemble it accumulates deletion and truncation byproducts whose masses sit close to the target. Chromatographic area percent can look clean while the dominant species is a near-neighbour, which is precisely what mass confirmation catches. The receptor pharmacology those byproducts would fail to reproduce is covered in how GLP-1 receptor signalling works.

Check 6 is the one most often absent and the only one that changes the price you paid. Lyophilized material carries counterion, residual solvent and water alongside peptide, so a milligram figure on a label is a solid mass, and the peptide fraction of it is whatever the COA says it is. At a reported 90% net peptide, a 20 mg vial holds 18 mg of retatrutide, which moves the rate you actually paid from $9.75/mg to $10.83/mg — worked through below.

Checks 2, 3 and 7 fail more quietly and are worth a second look. A test date that precedes the synthesis date, or no date at all, means the certificate belongs to some earlier lot and travelled with the listing rather than the vial; peptide purity is not a fixed property, since lyophilized material picks up moisture and degrades on a timescale that makes a two-year-old assay uninformative about what shipped. A named laboratory matters for the same reason a batch number does: a certificate you can take back to an independent lab and ask about is a claim someone else can be held to, while an unattributed report is an assertion in a table. Check 7 is narrower — it applies only when the listing itself advertises sterility or a low endotoxin figure, and its job is to catch the gap between what the marketing copy promises and what the instrument actually measured.

How do you check the vial delivers the milligrams on the label?

Convert the COA figures into concentration before you draw anything, because that is where a missing net peptide percentage becomes a measurable shortfall.

Start with the nominal case. A 20 mg vial reconstituted with 2 mL of bacteriostatic water gives 20 ÷ 2 = 10 mg/mL. A U-100 insulin syringe holds 100 units per mL, so each unit carries 10 ÷ 100 = 0.1 mg, or 100 mcg. An 8 mg measurement is 8 ÷ 10 = 0.8 mL, which reads as 80 units on that syringe.

Now apply a reported net peptide content. If a COA on that same vial reports 90% net peptide, the vial holds 20 × 0.90 = 18 mg of peptide, and the true concentration is 18 ÷ 2 = 9 mg/mL rather than 10. The 80-unit mark then delivers 0.8 × 9 = 7.2 mg, which is 0.8 mg short of the intended 8 mg, a 10% deficit that no purity percentage would have revealed. The real rate on that vial is $195 ÷ 18 = $10.83/mg instead of $9.75/mg.

The same arithmetic on the smaller vial shows why reconstitution volume, not vial size, sets the resolution you can measure at. A 10 mg vial taken up in 1 mL gives 10 ÷ 1 = 10 mg/mL, identical to the 20 mg vial in 2 mL, so an 8 mg draw is again 0.8 mL or 80 units. Take that same 10 mg vial up in 2 mL instead and the concentration halves to 5 mg/mL, at which point 8 mg is 8 ÷ 5 = 1.6 mL — more than a U-100 syringe holds in one pull. Dilute volumes buy precision on small quantities and cost it on large ones, so reconstitution volume should be chosen from the quantity you intend to draw rather than from the vial’s nominal size. Apply the net peptide correction second, always, because it shifts every concentration derived above it.

A vendor that reports net peptide content is therefore giving you a figure that can only make their own price look worse, which is why its presence is a stronger signal than any number printed next to it. Treat the per-mg column as a ceiling on value whenever the field is blank.

What do shipping and returns terms reveal about a supplier?

Storage form. Lyophilized retatrutide travels at ambient temperature, and HEEZ Research ships same day by UPS from Florida on orders placed before the 3 PM ET cutoff, at ambient rather than on ice. A supplier insisting on cold-chain freight for dry powder is either shipping something already in solution or pricing in a service the material does not need.

Returns policy sets the cost of skipping the checks above. All sales are final on the HEEZ listing, which is standard for research reagents and means Table 2 has to be run against the COA before the order, not after the vial arrives. There is no version of this where a failed verification is recoverable at the vendor’s expense.

What arrives is worth documenting on the day it lands. Photograph the vial label against the packing slip, check that the batch number on the label is the one on the certificate you were sent before ordering, and confirm the stopper seal is intact and the cake inside is dry and unshrunken rather than a collapsed film or a residue ring. A lyophilized cake that has partially melted and re-dried has been through a temperature excursion no shipping label records, and that is the one condition worth raising with the supplier the day it arrives rather than a week later. Once the cake looks right, storage becomes the buyer’s variable: dry powder is stable well beyond the transit window under refrigeration, while reconstituted material is a solution with a far shorter useful life, which is the argument for reconstituting one vial at a time rather than a batch.

Common questions about buying retatrutide

Where can I buy retatrutide online in the USA? From research-material suppliers shipping domestically, to qualified organizations only. HEEZ Research dispatches from Florida the same day on orders before 3 PM ET, so the two catalog sizes land as domestic freight with no import step and no cold-chain surcharge.

Is retatrutide for sale in 10 mg and 20 mg only? Those are the two catalog sizes, at $100 and $195 respectively as of September 2026 from the HEEZ catalog. Quantities that do not divide evenly into 10 or 20 are met by rounding up to whole vials, since partial vials are not sold.

Does a 99% purity claim mean the vial contains 99% retatrutide? No. Purity stated as ≥99% by HPLC describes the share of detected material that is one dominant species, and MS identity is the separate measurement confirming that species is retatrutide. Net peptide content is a third figure again, describing how much of the labeled solid is peptide at all.

Can I get a prescription for retatrutide instead? No prescriber can write one, because there is no approved indication to write against. The TRIUMPH program’s primary endpoints are percent change in body weight for weight management, change in Apnea-Hypopnea Index for obstructive sleep apnea, and change in the WOMAC pain subscale score for knee osteoarthritis, with type I error controlled at α = 0.05 split between the overarching weight management analysis and each basket trial (PMID 41090431).